Both the human and the mouse bax promoters contain p53 binding sites which are sucient to confer p53-dependent transcriptional activation in a heterologous setting. Nevertheless in the context of the bax promoter, these sites do not mediate a p53-dependent response, suggesting that bax may not be a direct transcriptional target of p53. Here, data are presented identifying a conserved p53 response element in the ®rst intron of both the human and the murine bax genes. This element both in isolation and in the context of the ®rst intron conferred p53-dependent transcriptional activation upon a minimal promoter. Electrophoretic mobility shift assays demonstrated that this sequence also is capable of mediating sequence speci®c binding to p53. p53 eectively activated transcription through both human and murine bax gene reporter constructs, whereas deletion of the intronic response element abrogated the p53-responsiveness of both reporters. Interestingly, tumor-derived mutants of p53 which are defective in inducing an apoptotic response retain the ability to activate transcription via the bax intronic p53 site. Since these mutants are transcriptionally inactive on the p53 site in the bax promoter, the ability of these mutants to up-regulating endogenous bax mRNA levels supports a role for the intronic element in p53-dependent up-regulation of bax expression. Taken together, these results show the requirement for a novel intronic element in the p53-dependent transcriptional activation of bax, and demonstrate that bax is indeed a direct and evolutionarily conserved transcriptional target of p53 Oncogene (2002) 21, 990 ± 999.
Introduction
Bax is an important mediator of apoptosis. In the mitochondria, homodimeric Bax is capable of releasing cytochrome c to the cytoplasm (Jurgensmeier et al., 1998; Manon et al., 1997; Pastorino et al., 1998) . Once in the cytoplasm, cytochrome c functions as a cofactor with Apaf-1 to promote the cleavage of pro-caspase-9, initiating apoptosis (Skulachev, 1998) . Two homologues, Bcl-2 and Bcl-x L , antagonize Bax function by heterodimerizing with it in the mitochondria, blocking the release of cytochrome c (Kim et al., 1997; Oltvai et al., 1993) . An important determinant of the apoptotic response is the balance between the levels of Bax and Bcl-2/Bcl-x L . Regulation of Bax protein expression, therefore, is a key factor in this process.
The tumor suppressor protein p53 has been shown to regulate bax expression (Miyashita et al., 1994; Miyashita and Reed, 1995) . At its amino-terminus, the p53 protein contains a potent transcriptional activation domain (Fields and Jang, 1990) which is linked to a central core domain that mediates sequence-speci®c DNA binding (Bargonetti et al., 1993; Pavletich et al., 1993; Wang et al., 1993) . Both of these domains are important for p53-mediated growth suppression (Pietenpol et al., 1994) . A DNA consensus sequence through which p53 binds and activates transcription has been identi®ed. This sequence consists of two palindromic decamers of 5'-RRRCWWGYYY-3' (where R is a purine, Y is a pyrimidine, and W is an adenine or thymine) separated by 0 ± 13 bp (el-Deiry et al., 1992; Funk et al., 1992) . Miyashita and Reed (1995) identi®ed the human bax gene as a transcriptional target of p53 (Miyashita et al., 1994) . Supporting this notion, a p53 response element in the promoter of the human bax gene has been demonstrated at 7113 to 783 from the start site of transcription (Miyashita and Reed, 1995; Thornborrow and Manfredi, 1999) . The recent cloning of the murine bax promoter, however, has questioned the signi®cance of this response element. Two independent reports have demonstrated that the murine bax promoter is unresponsive to p53 (Igata et al., 1999; Schmidt et al., 1999) , suggesting a lack of evolutionary conservation with respect to the ability of p53 to transcriptionally regulate bax expression.
To assay for additional sequence elements that in¯uence p53-dependent transcriptional activation, extended pieces of both the human and murine bax genes were cloned. Data presented here is demonstrating that both the human and murine bax genes are direct transcriptional targets of the tumor suppressor protein p53. Sequence analysis of these two genes identi®ed two regions conserved between human and mouse. The ®rst region corresponds to the previously characterized p53 response element in the human bax promoter at 7113 to 783 from the start site of transcription. The second region of conservation is found in the ®rst intron of both genes and resembles the p53 DNA-binding consensus sequence. Both regions in the human and murine bax genes are capable of binding p53 in a sequence speci®c manner in vivo and of conferring p53 responsiveness upon a minimal promoter in cells. Further, it is demonstrated that the p53 response element in the ®rst intron of the human and murine bax genes is both required and sucient for p53-dependent transcriptional activation.
Results
The p53 response element of the human bax promoter is partially conserved in the murine promoter Two reports have demonstrated that the murine bax promoter is unresponsive to p53 in transient transfection assays (Igata et al., 1999; Schmidt et al., 1999) . The p53-dependent regulation of Bax expression, however, has been observed in numerous tissues and cell types of the mouse (Miyashita et al., 1994; Bouvard et al., 2000) . To explore this further, a 1440 bp fragment (7898 to +542 from the start site of translation) of the murine bax gene was PCR cloned from mouse genomic DNA (Accession #AF339055) and analysed for sequences that contribute to p53-dependent regulation. A p53 response element was previously identi®ed in the human bax promoter at 7113/783 from the start site of transcription (Miyashita and Reed, 1995; Thornborrow and Manfredi, 1999) . This sequence was found to be partially conserved in the murine promoter at 7339/7304 from the start site of translation (Figure 1 ). Of the 31 bp that contribute to the p53 response element in the promoter of the human bax gene (Figure 1 , Human(7113/783) sequence), 19 bases are conserved in the mouse promoter (Figure 1 , solid lines) and an additional six bases represent conservative substitutions of purine for purine or pyrimidine for pyrimidine ( Figure 1, dashed lines) . As with the human sequence, if one applies the p53 DNA-binding consensus sequence of 5'-RRRCWWGYYY-3' to this region, three potential p53 half-sites are identi®ed (Figure 3 , white boxes labeled 1 ± 3). Of note is the Cytosine (C) at position 7332 (Figure 1, arrow) . This base is consistent with the murine bax promoter sequence published by Schmidt et al. (1999) , but is not found in the sequence published by Igata et al. (1999) nor is it found in their accompanying GenBank submission (Accession #AB029557). To con®rm the presence of this base, this region was PCR cloned from mouse genomic DNA on ®ve independent occasions. In each case the C was present at position 7332.
To determine if there is functional conservation of the promoter response element, synthetic oligonucleotides corresponding to 7113/783 in the human bax gene and to 7341/7302 in the murine bax gene were cloned upstream of a minimal promoter and cotransfected into the p53-de®cient Saos-2 cell line with an expression vector for wild-type p53 (Figure 2a ). Wildtype p53 eectively activated transcription through the response element from the human bax promoter (Figure 2a, HuBax7113/783) . The murine bax sequence also was activated signi®cantly by p53 (Figure 2a, MuBax7342/7302) . The level of activation observed with the murine element, however, was reduced as compared to that seen with the human sequence ( Figure 2a , compare 98-fold with HuBax7113/783 to 19-fold with MuBax7341/7302). A reporter containing an unrelated sequence from the human bak promoter did not respond to p53 (Figure 2a, Bak) . Similar results were observed in cotransfection assays using an expression vector for wild-type murine p53 (data not shown).
The ability of p53 to directly bind the murine sequence from 7341/7302 was addressed using electrophoretic mobility shift assay (EMSA). Oligonucleotides corresponding to either this sequence (Figure 2b, upper panel) or the human sequence from 7113/ 783 (Figure 2b , lower panel) were used as radiolabeled probes in EMSAs. Puri®ed p53 bound both radiolabeled probes (Figure 2b , lane 1), and was eectively competed by increasing amounts of unlabeled human and murine bax oligonucleotides ( Figure 2b , lanes 2 ± 4 and 5 ± 7 respectively). An unrelated oligonucleotide, Sens-1, failed to compete for p53 binding with either Figure 1 Cloning of the murine bax gene demonstrates sequence conservation of the promoter p53 response element. The murine bax gene from 7898 to +542 from the start site of translation was PCR cloned (Accession # AF339055) from mouse genomic DNA. This region is schematically represented with the black boxes indicating the positions of exons 1 (+1 to +34) and 2 (partial sequence: +505 to +542). The white box labeled 7339 to 7304 indicates a region of conservation between the mouse and human sequences. The nucleotide sequences of this region are listed. For comparison the region of the human bax gene that demonstrates conservation is listed above the mouse sequence. The numbering of the human sequence is with respect to the start site of transcription. A solid line between the two sequences indicates perfect conservation at that base. Dashed lines indicate a conservative substitutions of purine for purine or pyrimidine for pyrimidine. The white boxes, labeled 1 ± 3, indicate the p53 response element half-sites from the human gene and the corresponding murine sequences. The asterisks indicate bases that deviate from the p53 DNA-binding consensus sequence. The arrow indicates a cytosine at position 7332 that was not reported in the original cloning of the murine bax promoter (Igata et al., 1999) probe ( Figure 2b , lanes 8 ± 10), demonstrating that the binding of p53 to both the human and murine bax promoter elements is speci®c.
Reporter plasmids were constructed containing either the 7897/752 or the 7402/752 sequence from the start site of translation of the murine bax promoter to test the signi®cance of the response element at 7339/7304 in the context of the bax promoter. Consistent with previously published results (Igata et al., 1999; Schmidt et al., 1999) , p53 failed to mediate transcriptional activation through either murine promoter construct while successfully activating a reporter plasmid containing 7315/+51 from the start site of transcription of the human bax promoter (Figure 2c ). These data suggest a discrepancy between the ability of p53 to activate transcription through the human bax promoter as compared to the murine promoter. To examine this further, the ability of a larger fragment of the human promoter to mediate p53-dependent activation was tested. p53 failed to activate a reporter plasmid containing 7318/+372 from the start site of transcription of the human bax promoter while successfully activating the smaller 7315/+51 promoter construct (Figure 2d ), demonstrating that, as seen with the mouse promoter, the p53 binding site in the context of a larger fragment of the human bax promoter is also unresponsive to p53. These results suggest that a negative regulatory element may exist between +51 and +372 in the 5' untranslated region (5'UTR) of the human bax gene that inhibits the ability of p53 to mediate activation through its binding site in the promoter.
Cloning of the human and murine bax genes identifies a novel p53 response element in the first intron that is required for p53-dependent activation
Since the bax promoter was unresponsive to p53, the murine bax gene was further analysed for additional sequences that may participate in the p53-dependent regulation of bax transcription. Sequence analysis of the ®rst intron revealed 20 bp at +183/+202 from the start site of translation that match the p53 DNAbinding consensus sequence at 18 of 20 bases ( Figure  3a , white boxes, mismatches indicated by asterisks). This sequence was con®rmed in ®ve independent PCRs of mouse genomic DNA. To assess whether or not this sequence is evolutionarily conserved, a 1599 bp fragment (7571/+1028 from the start site of transcription) of the bax gene was PCR cloned from human genomic DNA (Accession #AF339054). A 43 bp region at +651/+693 was found to be 93% identical to the murine bax sequence at +177/+219 (Figure 3 , solid lines represent identities, dashed lines represent conservative substitutions). Further, the putative p53 response element at +183/+202 in the mouse gene is perfectly conserved in the ®rst intron of the human gene at +657/+676 from the start site of transcription. The human sequence was con®rmed in three independent PCRs of human genomic DNA, and, subsequently, has been con®rmed independently by the Human Genome Project (Accession #11425312).
To determine whether the sequence from +657/ +676 in the human bax gene (+177/+219 in the murine bax gene) constitutes a bona ®de p53 response element, a synthetic oligonucleotide corresponding to this sequence was used as a radiolabeled probe in an EMSA with puri®ed p53 (Figure 3b ). Puri®ed p53 bound the labeled oligonucleotide containing the putative response element (Figure 1b , lane 1), and this binding was eectively competed by an excess of the same, unlabeled oligonucleotide ( Figure 3b , lanes 5 ± 7). An oligonucleotide corresponding to the p53 response element at 7113/783 from the start of transcription in the human promoter also competed for p53 binding ( Figure 3b , lanes 2 ± 4). An unrelated control oligonucleotide, Sens-1, was unable to compete for p53 binding (Figure 3b , lanes 8 ± 10), demonstrating that the binding of p53 to +657/+676 is sequence-speci®c. The murine bax gene from 7898 to +542 from the start site of translation is schematically represented with the black boxes indicating the positions of exons 1 (+1 to +34) and 2 (partial sequence: +505 to +542). The white box labeled 7339 to 7304 indicates the previously described p53 response element (see Figure 1) . The white box labeled +183 to +202 indicates a region of conservation between the mouse and human sequences. The nucleotide sequences of this region is listed. For comparison the region of the human bax gene (Accession #AF339054) that demonstrates conservation is listed below the mouse sequence. The numbering of the human sequence is with respect to the start site of transcription. A solid line between the two sequences indicates perfect conservation at that base. Dashed lines indicate conservative substitutions of purine for purine or pyrimidine for pyrimidine. The asterisks indicate bases that deviate from the p53 DNA-binding consensus sequence. (b) An electrophoretic mobility shift assay was performed using an oligonucleotide corresponding to the +657/+676 sequence from the human bax gene (identical to +183/+202 in the mouse) as radiolabeled probe. Fifty ng of puri®ed p53 was incubated with 3 ng of the probe alone (lane 1) or in the presence of a 500-, 1000-, or 1500-fold molar excess of either the unlabeled HuBax7113/ 783 oligonucleotide (lanes 2 ± 4), the HuBax+657/+676 oligonucleotide (lanes 5 ± 7), or the Sens-1 oligonucleotide (lanes 8 ± 10). The arrow indicates the position of the p53-DNA complex
The signi®cance of this 20 bp element to p53-dependent activation in cells was addressed in transient transfection assays. Luciferase reporter plasmids containing dierent regions of the human bax gene were constructed ( Figure 4a ) and cotransfected with a wildtype p53 expression vector into the Saos-2 cell line (Figure 4 ). When cloned upstream of a minimal promoter, the ®rst intron of the human bax gene (Figure 4a , Hu+408/+989) mediated a signi®cant degree of activation in response to p53 (Figure 4b , Hu+408/+989). Deletion of the putative p53 response element at +657/+676 (Figure 4a , Hu+408/ +989DIn) abolished the ability of p53 to transcriptionally activate (Figure 4b , Hu+408/+989DIn), demonstrating that the ®rst intron of the human bax gene can confer p53 responsiveness upon a minimal promoter and that the p53 response element at +657/ +676 is required for this activity. To determine if this 20 bp element is sucient to mediate p53-dependent transcriptional activation, an oligonucleotide corresponding to this sequence was cloned into the minimal promoter reporter (Figure 4a , HuBax+657/+676). This reporter plasmid mediated a signi®cant degree of activation in response to p53 (Figure 4c , HuBax+657/ +676). Thus, the 20 bp from +657/+676 is sucient to confer p53-dependent transcriptional activation upon a minimal promoter. A reporter with no insert as well as a reporter containing an unrelated sequence from the human bak promoter failed to respond to wild-type p53 (Figure 4c , Empty and Bak). Similar results were also obtained with a reporter containing a p53 response element from the human p21 promoter which had been mutated such that it no longer bound to p53 as determined by EMSA (data not shown).
To address the signi®cance of this intronic p53 response element in the larger context of the human bax gene, a reporter plasmid was made in which the bax gene from 7571 to +1028 was cloned in frame with luciferase, forming a fusion between exon 2 of bax and the luciferase of pGL3-Basic (Figure 4a , HuBax). wt . Where appropriate, amounts of the vector pCMV were added to each transfection mixture to maintain a constant level of total plasmid DNA. Twenty-four hours post transfection cells were lysed and assayed for total protein and luciferase activity. The indicated values are the average of three independent experiments each performed in duplicate. Error bars correspond to one standard deviation p53-dependent transactivation of bax EC Thornborrow et al When transfected into Saos-2 cells, this reporter plasmid mediated a signi®cant degree of transcriptional activity in response to a cotransfected p53 expression vector (Figure 4d , HuBax). There was no substantial dierence between the p53 responsiveness of this reporter as compared to a reporter in which the previously characterized p53 response element at 7113/783 is deleted (Figure 4a , HuBaxDPr) ( Figure  4d , compare 3.5 ± 3.8-fold with HuBax to 2.8 ± 3.3-fold with HuBaxDPr). Deletion of the intronic region containing the newly identi®ed p53 response element (Figure 4a, HuBaxDIn) , however, produced a reporter that was unresponsive to wild-type p53 (Figure 4d , HuBaxDIn), demonstrating that this element is required for p53 to mediate transcriptional activation of the human bax gene. Given the perfect conservation of the intronic p53 binding site, the above results with the human bax reporter plasmids (Figure 4b ,d) were compared with a similar set of constructs based on the murine gene. A reporter plasmid was made in which the murine bax gene from 7898 to +542 from the start site of translation was cloned in frame with luciferase, again forming a fusion between exon 2 of bax and the luciferase of pGL3-Basic (Figure 5a , MuBax). When cotransfected with a p53 expression vector into Saos-2 cells this reporter plasmid was transcriptionally activated (Figure 5a , MuBax). As observed with the human bax gene (Figure 4d) , there was no signi®cant dierence between the p53-dependent transactivation of this reporter as compared to a reporter in which the p53 response element at 7339/7304 is deleted ( Figure  5a , compare MuBax to MuBaxDPr). Deletion of the intronic region containing the newly identi®ed p53 response element, however, produced a reporter construct that was unresponsive to wild-type p53 (Figure 5a, MuBaxDIn) . Also, the isolated intron from the murine bax gene conferred p53-responsiveness on a minimal promoter, while this same reporter with the p53 response element at +183/+202 deleted did not (Figure 5b ). Together, these results demonstrate that this intronic element is required for p53 to mediate transcriptional activation of the murine bax gene, as was the case with the human gene.
Two tumor-derived mutants of p53, 181L and 175P, have been shown to be capable of activating transcription through the p21 promoter but to fail to do so through the bax promoter. This failure to activate the bax promoter correlated with the inability of these mutants to induce apoptosis (Ludwig et al., 1996) . The ability of the 181L and 175P p53 mutants to activate transcription through various p21 and bax reporter plasmids was assayed by transient transfection in Saos-2 cells (Figure 6 ). Wild-type p53 ( Figure 6 , white bars) successfully activated transcription through each reporter construct assayed. In addition to wild-type p53, the 181L (dark gray bars) and 175P (black bars) mutants also mediated a signi®cant amount of activation through the 5' p53 response element of the human p21 promoter (p21-5') cloned upstream of a minimal promoter (Figure 6, pTATAp21-5' ). Consistent with studies using the bax promoter, however, these mutants failed to activate transcription through the p53 response element of the human bax promoter (Figure 6, pTATA7113/783) . In contrast to 7113/ 783, yet similar to p21-5', the 181L and 175P mutants successfully activated transcription through the intronic p53 response element of the bax gene ( Figure 6 , pTATA+657/+676) as well as through the HuBax reporter (Figure 6 , HuBax), which contains 7571/ +1028 of the human bax gene cloned in frame with luciferase (see Figure 4a ). In the case of both the bax intronic and p21-5' elements the levels of activation observed with the p53 mutants were less than that observed with wild-type p53. This is consistent with the observation that, as compared to wild-type p53, the two mutants were expressed at a slightly lower level in Saos-2 cells (data not shown). The eect of these mutant proteins on endogenous bax expression was then examined. Saos-2 cells were transfected with expression plasmids for wild-type p53 as well as the 175P and 181L mutant p53 proteins. Levels of endogenous p21, bax, and GAPDH mRNA were then determined by RT ± PCR (Figure 7) . Expression of all three p53 proteins caused up-regulation of both p21 and bax mRNA without aecting the level of GAPDH mRNA. Since these mutants are transcriptionally inactive on the p53 site in the bax promoter, this ability of the mutant p53 proteins to increase endogenous bax mRNA levels supports a role for the intronic element in p53-dependent up-regulation of endogenous bax expression.
Discussion
Thymocytes from the bax knock-out mouse continue to undergo p53-dependent apoptosis in response to ionizing radiation, suggesting that Bax up-regulation is not necessary (Knudson et al., 1995) . Recent studies with the bax/bak double knock-out mouse have shown that bax does indeed play an important role in this process. These experiments demonstrated that while thymocytes from either the bax or the bak knock-out mouse undergo p53-dependent apoptosis, thymocytes from the bax/bak double knock-out do not, suggesting that these two gene products are functionally redundant in this cell type and are together important downstream eectors of p53-dependent apoptosis (Lindsten et al., 2000) . Wei et al. (2001) have further substantiated these results in cell culture showing that either bax or bak is required for apoptosis triggered by almost all forms of stimuli, including those that are p53-dependent. In fact, p53-dependent regulation of Bax expression has been observed in the prostate, thymus, spleen, small intestine, and lung, as well as sympathetic, Purkinjie, and olfactory cortical neurons of the mouse (Miyashita et al., 1994; Bouvard et al., 2000) . Further, Bax has been shown both to be an obligatory downstream eector for the p53-mediated apoptosis that attenuates choroid plexus tumor growth in the TgT121 mouse model (Yin et al., 1997) , and to function as an eector of p53-dependent apoptosis and a suppressor of oncogenic transformation in mouse embryo ®broblasts (McCurrach et al., 1997) . Studies showing that the mouse bax promoter is not p53 responsive, however, raised the question of whether bax is a direct transcriptional target of p53 in the mouse (Igata et al., 1999; Schmidt et al., 1999) . In humans, Zhang et al. (2000) demonstrated in colorectal cancer cells that bax is responsible for approximately Figure 6 The p53 mutants 181L and 175P successfully activate transcription through the intronic response element. Saos-2 cells were transfected with 1 mg of the indicated reporter plasmids in the presence of either 100 ng (HuBax) or 10 ng (pTATA7113/ 783, +657/+676, and p21-5') of pCMV (light gray bars), pCMV-p53 wt (white bars), 181L (dark gray bars), or 175P (black bars). Twenty-four hours post transfection cells were lysed and assayed for total protein and luciferase activity. The indicated values are the average of three independent experiments each performed in duplicate. Error bars correspond to one standard deviation p53-dependent transactivation of bax EC Thornborrow et al 50% of the p53-dependent apoptosis observed in response to 5-¯uorouracil treatment. While Bax is clearly not the only downstream eector in p53-dependent apoptosis, it does contribute signi®cantly to this response. Although Miyashita and Reed (1995) identi®ed a p53 response element in the human bax promoter, a recent study, subsequently con®rmed here (Figure 2d ), showed that a reporter containing 1 kb of promoter sequence fails to respond to p53 (Igata et al., 1999) . The data presented in this report demonstrate the existence of a novel p53 response element in the ®rst intron of the bax gene (Figures 3 ± 5 ). This element is found to be perfectly conserved between the human and murine bax genes (Figure 3) . Further, it is shown that this element is both sucient and necessary for p53 to mediate transcriptional activation of the bax gene in both species (Figures 4 and 5) . In addition, we have demonstrated partial conservation of the p53 response element of the human bax promoter in the murine promoter at 7339 to 7304 (Figures 1 and 2 ). This sequence from the murine bax promoter is capable of binding p53 in a sequence speci®c manner in vivo and of conferring p53-dependent transcriptional activation upon a minimal promoter in cells (Figures 2a,b) . Consistent with previously published data (Igata et al., 1999) , however, the promoter element, in the context of both the human and murine bax genes, appears to be neither sucient nor necessary for p53-dependent transactivation ( Figures 2, 4 and 5), at least in the cell line and under the conditions examined here. The tumorderived p53 mutants, 181L and 175P, which are defective in inducing an apoptotic response (Ludwig et al., 1996) retain the ability to activate transcription via the bax intronic p53 site. Since these mutants are transcriptionally inactive on the p53 site in the bax promoter, the ability of these mutants to up-regulating endogenous bax mRNA levels supports a role for the intronic element in p53-dependent up-regulation of bax expression. Further, the results with the human bax promoter demonstrate that the addition of 321 bp of the 5'UTR renders an otherwise responsive bax promoter unresponsive to p53 (Figure 2d ). This result suggests that an inhibitory sequence exists in the 5'UTR of bax, and oers the possibility that the promoter element may be functional in cells in which this inhibition does not occur.
Clearly the p53-dependent regulation of bax is complex likely involving two unique p53 response elements, one in the promoter and one in the ®rst intron, as well as a potential negative regulatory element in the 5'UTR. The results presented here, however, do demonstrate that both the human and murine bax genes can function as direct transcriptional targets of the tumor suppressor protein p53, and that this response appears to involve a newly identi®ed response element in the ®rst intron. Thus, these results con®rm and substantiate the important role of bax as a direct and evolutionarily conserved target of p53-dependent transcriptional activation.
Materials and methods

Cells
The osteosarcoma Saos-2 cell line was maintained in a humidi®ed incubator at 378C with 5% CO 2 . Cells were grown in Dulbecco's modi®ed Eagle's medium, containing 10% heat inactivated fetal bovine serum, 100 units/ml penicillin, and 100 mg/ml streptomycin.
Oligonucleotides
For use in electrophoretic mobility shift assays and for subsequent cloning into luciferase reporter plasmids, complementary single-stranded oligonucleotides were annealed to produce double-stranded oligonucleotides with the indicated sequences: HuBax7113/783, AATTCGGTACCTCACAA-GTTAGAGACAAGCCTGGGCGTGGGCGCTAGCGAA-TT; HuBax+657/+676, AATTCGGTACCGGGCAGGCC-CGGGCTTGTCGGCTAGCGAATT; MuBax7341/7302, AATTCGGTACCGATGACAAGCATATCCCAGGCAAG-CTTTGAACTTGCGGCAGCTAGCGAATT; MuBax7341/ 7315, AATTCGGTACCGATGACAAGCATATCCCAGG-CAAGCTTGCTAGCGAATT; MuBax7324/7315, AATT-CGGTACCAGGCAAGCTTTGAACTTGCGGCAGCTA-GCGAATT; Bak, AATTCGCTAGCGGGCCAGGCCCAG-GAGCATGTCCCGCCCACTTTCCCGGTACCGAATT; Sens-1, AATTCGGTACCTCGAAGAAGACGTGCAGG-GACCCGCTAGCGAATT; p21-5', AATTCGGTACCGAA-CATGTCCCAACATGTTGGCTAGCGAATT.
Plasmids
With respect to the human bax gene, numbering is in reference to the start of transcription, while in the mouse gene numbering is from the start of translation. The following synthetic double-stranded oligonucleotides were cloned into the KpnI and NheI restriction sites of pTATA, originally referred to as pGL3-E1bTATA (Resnick-Silverman et al., 1998) , to produce vectors with corresponding names: HuBax7113/783, HuBax+657/+676, MuBax7341/7302, MuBax7341/7315, MuBax7324/7315, p21-5', and Bak. Hu+408/+989 was generated by PCR ampli®cation of intron 1 (+408 to +989) of the bax gene from human genomic DNA (Clonetech). PCR primers contained appropriate sequence for the subsequent cloning of this product into the EcoRI and SacI sites of the pTATA reporter plasmid. A PCR-based strategy was used to replace the region in Hu+408/+989 corresponding to +657 to +676 with the NcoI restriction site to produce Hu+408/+989DIn. Mu+1/+541 was generated by PCR ampli®cation of +1 to +541 of the bax gene from murine genomic DNA (Clonetech), and subsequent cloning of this product into the KpnI and NheI sites of the pTATA reporter plasmid. The region of Mu+1/+541 corresponding to +183 to +202 was replaced with the SacI restriction site to produce Mu+1/ +541DIn.
HuBax was generated by PCR ampli®cation of 7571 to +1028 of the bax gene from human genomic DNA (Clonetech). PCR primers were based on previously published promoter and exon sequence data and contained the appropriate sequence for the subsequent cloning of this product into the MluI and NcoI restriction sites of the pGL3-Basic reporter plasmid, maintaining the reading frame between the bax coding domain and the luciferase of pGL3-Basic. HuBaxDPr and HuBaxDIn were derived from HuBax by replacing the relevant sequences, 7113 to 784 and +652 to +676 respectively, with the BglII restriction site. HuBax7315/+51, originally referred to as pBax7315/ +51, was as described previously (Thornborrow and Manfredi, 2001 ). HuBax7318/+372 was generated by PCR ampli®cation of 7318 to +372 of the bax gene from HuBax. The PCR product was cloned into the NheI and HindIII restriction sites of pTATA, replacing the adenovirus E1b minimal promoter.
MuBax was generated by PCR ampli®cation of 7898 to +542 of the bax gene from mouse genomic DNA (Clonetech). Primers were based on previously published promoter and exon sequence. This PCR product was cloned into the KpnI and NcoI restriction sites of the pGL3-Basic reporter plasmid, maintaining the reading frame between the bax coding domain and the luciferase of pGL3-Basic. MuBaxDPr and MuBaxDIn were derived from MuBax by replacing the relevant sequences, 7339 to 7304 and +183 to +202 respectively, with the BglII restriction site. MuBax7897/752 and MuBax7402/752 were generated by PCR ampli®cation from mouse genomic DNA (Clonetech). These PCR products were cloned into the KpnI and NheI restriction sites of the pGL3-Basic reporter plasmid. The validity of all reporter plasmids was con®rmed by sequencing.
The expression plasmid pCMV-p53 wt , originally referred to as pC53-SN3 (Baker et al., 1990) , encodes the wild-type human p53 protein under the control of the cytomegalovirus promoter. The mutant p53 expression vectors 181L and 175P encode the corresponding p53 mutant under the control of the cytomegalovirus promoter (Ludwig et al., 1996) .
Transfections
Saos-2 cells were transfected using Lipofectamine Plus Reagent (GibcoBRL, Life Technologies). 2610 5 cells were seeded into 35-mm plates. Cells were transfected 24 h later according to the manufacturer's instructions. Cellular lysates were prepared 24 h post-transfection, total protein concentration was determined by protein assay (Bio-Rad), and luciferase assays were quantitated using a commercially available kit (Promega) and a TD-20e Luminometer (Turner).
Electrophoretic mobility shift assay
Production of baculovirus-infected Sf9 cell extracts and puri®cation of recombinant human p53 protein was done as previously described (Resnick-Silverman et al., 1998) . Puri®ed p53 protein was incubated with 3 ng of radiolabeled doublestranded oligonucleotide in a total volume of 30 ml of DNAbinding buer (20 mM HEPES pH 7.5, 83 mM NaCl, 0.1 mM EDTA, 12% glycerol, 2 mM MgCl 2 , 2 mM spermidine, 0.7 mM DTT, and 25 mg/ml poly d(I ± C)) for 20 min at room temperature. Samples were loaded on a native 4% acrylamide gel in 0.56 TBE and electrophoresed at 48C at 225 V for 2 h. The gel was dried and exposed to Kodak XAR ®lm using an intensifying screen at 7708C.
RT ± PCR
Saos-2 cells were transfected using Lipofectamine Plus Reagent (GibcoBRL, Life Technologies). 1610 6 cells were seeded into 100-mm plates. Cells were transfected 24 h later according to the manufacturer's instructions. RNA was isolated with Ultraspec (Biotecx) 24 h post-transfection, and 1 mg was used immediately for cDNA synthesis with SuperScript RT (Life Technologies) according to the manufacturer's instructions. Primers used for PCR ampli®cation were: bax, 5'-CCCTGGACCCGGTGCCTCAGG-3'/5'-TCACGG-TCTGCCACGTGGGCGT-3'; p21, 5'-GGGGGCATCAT-CAAAAACTT-3'/5'-ACTGAAGGGAAAGGACAAGG-3'; GAPDH, 5'-GTGAAGGTCGGAGTCAAC-3'/5'-TGGAA-TTTGCCATGGGTG-3'; p53, 5'-CGCGGATCCATGGAG-GAGCCGCAGTCAG-3'/5'-CCCAAGCTTGTCAGTCTG-AGTCAGGCCC. PCR reactions were set up containing 16 PCR buer, 0.2 mM of each dNTP, 1.5 mM MgCl 2 , 150 ng of each primer, 2.5 units PLATINUM Taq DNA Polymerase (Life Technologies), 5% DMS, 2 ml template cDNA, 0.25 mCi a-32 P dATP and distilled water to 50 ml. PCR conditions for p21, GAPDH and p53 were 25 cycles: 45 s at 948C, 45 s at 558C and 1 min at 728C. Bax PCR was as above except the annealing temperature was at 658C. Samples were run on a 6% acrylamide gel and visualized using autoradiography. Phosphorimaging was performed with a Personal Molecular Imager FX and analysed with Quantity One software (BioRad).
